Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gui-Hua Zhong"'
Autor:
Ying-peng Peng, Qiao-dan Liu, Yu-jing Lin, Shun-li Peng, Rong Wang, Xi-wei Xu, Wei Wei, Gui-hua Zhong, Yu-ling Zhou, Ya-qin Zhang, Ye Liu, Si-yang Wang, Hai-yu Hong, Zhi-gang Liu
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-10 (2021)
Abstract Background Second head and neck neuroendocrine carcinoma (NEC) after radical radiotherapy for nasopharyngeal carcinoma (NPC) treatment is rarely reported. The prognosis of second cancer is poor, and our research focuses on finding a breakthr
Externí odkaz:
https://doaj.org/article/d6fabd35f01344dbaa4e489fa5926580
Autor:
Shun-Li Peng, Rong Wang, Yu-Ling Zhou, Wei Wei, Gui-Hua Zhong, Xiao-Tao Huang, Shuai Yang, Qiao-Dan Liu, Zhi-Gang Liu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Metabolic reprogramming is a novel method for the treatment of malignant tumors. The exploration of metabolism procedures between radiosensitive and radioresistant tumors may provide novel perspectives for lung adenocarcinoma (LUAD) patients after ra
Externí odkaz:
https://doaj.org/article/1218253df51a4d6d97e6058effaf1f52
Autor:
Yu-ling Zhou, Ying-peng Peng, Qiao-dan Liu, Xian-zhen Chen, Jianzhong He, Wei Wei, Gui-hua Zhong, Ya-qin Zhang, Ye Liu, Jia-ying Pan, Shao-yan Feng, Zhi-gang Liu
Publikováno v:
Cancer Control, Vol 29 (2022)
Background Nasopharyngeal small cell carcinoma (SmCC) is a rare histological type of nasopharyngeal cancer, and its prognosis remains poor. This study aimed to determine the clinical characteristics and survival prognostic factors of nasopharyngeal S
Externí odkaz:
https://doaj.org/article/9ed472a8bc9c4af29c029747b648b030
Autor:
Siyang Wang, Zhigang Liu, Ya-qin Zhang, Yu-jing Lin, Rong Wang, Wei Wei, Xi-Wei Xu, Gui-hua Zhong, Hai-yu Hong, Qiao-Dan Liu, Ye Liu, Ying-peng Peng, Shun-li Peng, Yu-ling Zhou
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-10 (2021)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background Second head and neck neuroendocrine carcinoma (NEC) after radical radiotherapy for nasopharyngeal carcinoma (NPC) treatment is rarely reported. The prognosis of second cancer is poor, and our research focuses on finding a breakthrough in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6aecca2b8fd63a497b6cddffcc679bb
https://doaj.org/article/d6fabd35f01344dbaa4e489fa5926580
https://doaj.org/article/d6fabd35f01344dbaa4e489fa5926580
Autor:
Zhigang Liu, Xi-Wei Xu, Jun Liang, Zhaoming Deng, Qiao-Dan Liu, Wei Wei, Gui-hua Zhong, Hongbo Zhang, Wei Liao, Chao He
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-9 (2021)
Cancer Cell International
Cancer Cell International
Background Oral squamous cell carcinoma (OSCC) has been one of the most malignant cancers in head and neck region. Anlotinib is a tyrosine kinase inhibitor targeting several receptors such as vascular endothelial growth factor receptor (VEGFR), fibro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b201bf2f29d3de97aa572d07b5af8d5
https://doaj.org/article/5385cdd522cb4eec83dbc7cf49f795e2
https://doaj.org/article/5385cdd522cb4eec83dbc7cf49f795e2